DE1965894C2 - 2-hydrazino-5-phenyl-3H-1,4-benzodiazepine derivatives and process for their preparation - Google Patents

2-hydrazino-5-phenyl-3H-1,4-benzodiazepine derivatives and process for their preparation

Info

Publication number
DE1965894C2
DE1965894C2 DE19691965894 DE1965894A DE1965894C2 DE 1965894 C2 DE1965894 C2 DE 1965894C2 DE 19691965894 DE19691965894 DE 19691965894 DE 1965894 A DE1965894 A DE 1965894A DE 1965894 C2 DE1965894 C2 DE 1965894C2
Authority
DE
Germany
Prior art keywords
parts
phenyl
benzodiazepine
hydrazino
volume
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE19691965894
Other languages
German (de)
Other versions
DE1965894A1 (en
Inventor
Yutaka Ashiya Hyogo Kuwada
Kanji Nishinomiya Hyogo Neguro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Priority to DE19691965894 priority Critical patent/DE1965894C2/en
Publication of DE1965894A1 publication Critical patent/DE1965894A1/en
Application granted granted Critical
Publication of DE1965894C2 publication Critical patent/DE1965894C2/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/161,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/181,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/20Nitrogen atoms
    • AHUMAN NECESSITIES
    • A47FURNITURE; DOMESTIC ARTICLES OR APPLIANCES; COFFEE MILLS; SPICE MILLS; SUCTION CLEANERS IN GENERAL
    • A47BTABLES; DESKS; OFFICE FURNITURE; CABINETS; DRAWERS; GENERAL DETAILS OF FURNITURE
    • A47B73/00Bottle cupboards; Bottle racks
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F26DRYING
    • F26BDRYING SOLID MATERIALS OR OBJECTS BY REMOVING LIQUID THEREFROM
    • F26B3/00Drying solid materials or objects by processes involving the application of heat
    • F26B3/02Drying solid materials or objects by processes involving the application of heat by convection, i.e. heat being conveyed from a heat source to the materials or objects to be dried by a gas or vapour, e.g. air
    • F26B3/10Drying solid materials or objects by processes involving the application of heat by convection, i.e. heat being conveyed from a heat source to the materials or objects to be dried by a gas or vapour, e.g. air the gas or vapour carrying the materials or objects to be dried with it
    • F26B3/12Drying solid materials or objects by processes involving the application of heat by convection, i.e. heat being conveyed from a heat source to the materials or objects to be dried by a gas or vapour, e.g. air the gas or vapour carrying the materials or objects to be dried with it in the form of a spray, i.e. sprayed or dispersed emulsions or suspensions

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Microbiology (AREA)
  • Mechanical Engineering (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

aufgearbeitet, wobei 2-Hydrazino-5-phenyI-7-trifluormethylr3H-l,4-benzodiazepin als kristallines Pulver vom Schmelzpunkt 127° C (Sinterung) bzw. 133 bis 135°C(unter Aufschäumen) erhalten wird.worked up, with 2-hydrazino-5-phenyI-7-trifluoromethylr3H-1,4-benzodiazepine as a crystalline powder from melting point 127 ° C (sintering) or 133 to 135 ° C (with foaming) is obtained.

Elementaranalyse: Berechnet für Ci^Hi3F3N4: C6037 H4.12 N 17,60 Gefunden: C60,06H3,96N17,40Elemental analysis: Calculated for Ci ^ Hi 3 F 3 N 4 : C6037 H4.12 N 17.60 Found: C60.06H3.96N17.40

Diese Form ist für dieses Verfahren ebenfalls geeignet.This shape is also suitable for this procedure.

Die Verbindung der Formel (III) kann beispielsweise nach dem Verfahren hergestellt werden, das in Journal of Organic Chemistry« 29,231 (1964) beschrieben istThe compound of formula (III) can, for example be prepared according to the procedure outlined in Journal of Organic Chemistry «29, 231 (1964)

Der Alkylrest R5 ist vorzugsweise ein Alkylrest mit 1 bis 6 Koiilenstoffatomen, z. B. ein Methylrest, Äthylrest, Propylrest, Isopropyirest, Butylrest, sek.-Butylrest, tert-Butylrest, Aryl- oder Hexylrest Der Aralkylrest für den R5 steht ist z. B ein Benzyl- oder PhenyläthylrestThe alkyl radical R 5 is preferably an alkyl radical having 1 to 6 carbon atoms, e.g. For example, a methyl radical, ethyl radical, propyl radical, Isopropyirest, butyl, sec-butyl, tert-butyl, aryl or hexyl radical is The aralkyl group for R 5 is z. B a benzyl or phenylethyl radical

Die Reaktion wird im allgemeinen in Gegenwart eines Lösungsmittel (z.B. Methanol, Äthanol und wäßrige Gemische von Methanol und Äthanol) bei etwa Raumtemperatur oder gegebenenfalls unter Erhitzen zum Siedepunkt des verwendeten Lösungsmittels durchgeführt Das Hydrazin wird in einer Menge von etwa 1 bis 10 Mol pro MoI der Verbindung (III) verwendetThe reaction is generally carried out in the presence of a solvent (e.g. methanol, ethanol and aqueous mixtures of methanol and ethanol) at about room temperature or optionally with heating to the boiling point of the solvent used. The hydrazine is used in an amount of about 1 to 10 moles per mole of the compound (III) are used

Die in dieser Weise hergestellten 2-Hydrazino-'5-phenyl-3H-l,4-benzodiazepinderivate (I) können nach üblichen Methoden, beispielsweise durch Abdampfen des Lösungsmittels vom Reaktionsgemisch, isoliert werden.The 2-hydrazino-'5-phenyl-3H-l, 4-benzodiazepine derivatives (I) prepared in this way can by customary methods, for example by evaporation of the Solvent from the reaction mixture, are isolated.

Die neuen Verbindungen der Formel (I) sind wertvolle Zwischenprodukte fiür die Herstellung der neuen S-TriazoIo[4,3-aIl,4]-bfc;izodiazepine gemäß Stammpatent 19 55 349, die muskelersck äffende, beruhigende und dämpfende Wirkungen haben und daher wertvoll als Muskelrelaxantien, Antikonvulsiva, Sedativa, Tranquilizer sind.The new compounds of the formula (I) are valuable intermediates for the preparation of the new S-TriazoIo [4,3-aIl, 4] -bfc; izodiazepine according to Master patent 19 55 349, which have muscular aping, calming and dampening effects and therefore are valuable as muscle relaxants, anticonvulsants, sedatives, tranquilizers.

Beispiel 1example 1

Zu einer Suspension von 3,4 Teilen 2-Amino-7-chlor-S-phenyl-SH-l.^-benzodiazepindihydrochlorid in 60 Raumteilen Methanol werden 1,25 Teile 80%iges Hydrazinhydrat gegeben. Die Suspension wird 40 Minuten gerührt, mit Wasser verdünnt und mit Methylenchlorid extrahiert Der Extrakt wird mit Wasser gewaschen und über wasserfreiem Natriumsulfat getrocknet, worauf das Lösungsmittel abgedampft wird. Der Rückstand wird aus einem Gemisch von Methylenchlorid und Benzol umkristallisiert, wobei 7-Chlor-2-hydrazino-5-phenyl-3H-l,4-benzodiazepin in Form von farblosen Prismen erhalten wird. Schmelzpunkt etwa 170° C (Bräunung); 202 bis 204° C (Zers.)To a suspension of 3.4 parts of 2-amino-7-chloro-S-phenyl-SH-l. ^ - benzodiazepine dihydrochloride in 60 Parts by volume of methanol are given 1.25 parts of 80% hydrazine hydrate. The suspension turns 40 Stirred minutes, diluted with water and extracted with methylene chloride. The extract is washed with Washed with water and dried over anhydrous sodium sulfate, whereupon the solvent was evaporated will. The residue is recrystallized from a mixture of methylene chloride and benzene, whereby 7-chloro-2-hydrazino-5-phenyl-3H-1,4-benzodiazepine is obtained in the form of colorless prisms. Melting point about 170 ° C (browning); 202 to 204 ° C (dec.)

Elementaranalyse: Berechnet WrC15HuCIN4: C 63,27 H 4,60 N 19,68 Gefunden: C 63,43 H 4,48 N 19,27Elemental Analysis: Calculated WrC 15 HuCIN 4 : C 63.27 H 4.60 N 19.68 Found: C 63.43 H 4.48 N 19.27

Beispiel 2Example 2

Zu einem Gemisch von 9,1 Teilen 2-Amino-5-phenyl-7-trifluormethyl-3H-l,4-benzodiazepin, 150 Raumteilen Äthanol und 3,6 Raumteilen Eisessig werden 4,5 Raumteile 100%iges Hydrazinhydrat gegeben. Das Gemisch wird 30 Minuten bei Raumtemperatur gerührt und auf die in Beispiel 1 beschriebene WeiseTo a mixture of 9.1 parts of 2-amino-5-phenyl-7-trifluoromethyl-3H-1,4-benzodiazepine, 150 parts by volume Ethanol and 3.6 parts by volume of glacial acetic acid are given 4.5 parts by volume of 100% hydrazine hydrate. That The mixture is stirred for 30 minutes at room temperature and in the manner described in Example 1

Beispiel 3Example 3

. Zu einem Gemisch von 5,6 Teilen 2-Amino-7-nitro-5-phenyI-3H-l,4-benzodiazepin, 200 Raumteilen Äthanol. To a mixture of 5.6 parts of 2-amino-7-nitro-5-phenyI-3H-1,4-benzodiazepine, 200 parts by volume of ethanol und 2,4 Raumteilen Eisessig werden unter Rühren 5 Raumteile 80%iges Hydrazinhydrat gegeben. Das Gemisch wird 30 Minuten bei Raumtemperatur gerührt und auf die in Beispiel 1 beschriebene Weise aufgearbeitet, wobei 2-Hydrazino-7-nitro-5-pheny-!-3H-and 2.4 parts by volume of glacial acetic acid, 5 parts by volume of 80% hydrazine hydrate are added with stirring. That The mixture is stirred for 30 minutes at room temperature and in the manner described in Example 1 worked up, with 2-hydrazino-7-nitro-5-pheny -! - 3H- 1,4-benzodiazepin als rötliche, viskose ölige Substanz erhalten wird.1,4-benzodiazepine as a reddish, viscous oily substance is obtained.

Beispiel 4Example 4 Zu einer Lösung von lfr Teilen 2-Amino-7-chlor-3-To a solution of 1fr parts of 2-amino-7-chloro-3-

isobutyl-5-phenyl-3H-l,4-benzodiazepin und 25 Teilenisobutyl-5-phenyl-3H-1,4-benzodiazepine and 25 parts 100°/oigem Hydrazinhydrat in 400 Raumteilen Methanol100% hydrazine hydrate in 400 parts by volume of methanol werden 6 Teile Eisessig gegeben, während gerührt und6 parts of glacial acetic acid are added while stirring and

mit Eis gekühlt wird. Da* Gemisch wird dann 5 Stundenis cooled with ice. The * mixture will then be 5 hours bei Raumtemperatur gerührt Nach Zusatz von Wasserstirred at room temperature. After adding water zum Reaktionsgemisch wird mit Chloroform extrahiertthe reaction mixture is extracted with chloroform

Die Chloroformschicht wird mit Wasser gewaschen undThe chloroform layer is washed with water and

über Natriumsulfat getrocknet Das Lösungsmittel wirddried over sodium sulfate. The solvent is abgedampft Durch Behandlung des Rückstandes mitevaporated by treating the residue with

Isopropyläther wird 7-Chlor-2-hydrazino-3-isobutyl-5-Isopropyl ether becomes 7-chloro-2-hydrazino-3-isobutyl-5-

phenyl-3H-1,4-benzodiazepin in Form von farblosenphenyl-3H-1,4-benzodiazepine in the form of colorless

Kristallen vom Schmelzpunkt 165 bis 168° C erhalten.Crystals with a melting point of 165 to 168 ° C were obtained. Dieses Produkt ist mit dem gemäß Beispiel 7This product is the same as in Example 7

hergestellten Produkt identisch.manufactured product identical.

Beispiel 5Example 5

Zu einer Lösung von 2 Teilen 7-Chlor-2-methyImercapto-5-phenyI-3H-l,4-benzodiazepin in 70 Raumteilen Äthanol werden 5 Raumteile 80%iges Hydrazinhydrat gegeben. Das Gemisch wird 3 Tage bei RaumtemperaTo a solution of 2 parts of 7-chloro-2-methyImercapto-5-phenyI-3H-1,4-benzodiazepine in 70 parts by volume Ethanol is given to 5 parts by volume of 80% hydrazine hydrate. The mixture is left for 3 days at room temperature tür stehengelassen. Nach dem Abdampfen des Lösungs mittels wird zum Rückstand eine geringe Wassermenge gegeben, wobei 7-ChIor-2-hydrazino-5-phenyl-3H- 1,4-benzodiazepin in Form von Kristallen erhalten wird. Durch Umkristallisation aus einem Gemisch vonleft the door. After evaporation of the solution by means of a small amount of water is added to the residue, 7-chloro-2-hydrazino-5-phenyl-3H-1,4-benzodiazepine being obtained in the form of crystals. By recrystallization from a mixture of Methylenchlorid und Benzol werden Kristalle vom Schmelzpunkt 175° C (Bräunung) und 205 bis 2070C (Zers.) erhalten. Dieses Produkt ist mit dem gemäß Beispiel 1 hergestellten Produkt identisch.Methylene chloride and benzene are obtained crystals of melting point 175 ° C (browning) and 205-207 0 C (dec.). This product is identical to the product produced according to Example 1.

Beispiel 6Example 6

Zu einer Lösung von 2,9 Teilen 7-Chlor-13-dihydro-5-phenyI-2H-l,4-benzodiazepin-2-thion in einem Gemisch von 2,5 Raumteifen Dimethylsulfoxyd und 100 Raumteilen Äthanol werden 5 Raumteile 80%igesTo a solution of 2.9 parts of 7-chloro-13-dihydro-5-phenyI-2H-1,4-benzodiazepine-2-thione in a mixture of 2.5 space hard dimethyl sulfoxide and 100 Parts of the volume of ethanol are 5 parts of the volume of 80% Hydrazinhydrat gegeben. Das Gemisch wird 24 Stunden stehengelassen. Nach dem Abdampfen des Lösungsmitteis unter vermindertem Druck wird der Rückstand mit Wasser verdünnt, worauf mit Methylenchlorid extrahiert wird. Die Methylenchloridschicht wird überGiven hydrazine hydrate. The mixture will last 24 hours ditched. After evaporation of the solvent under reduced pressure, the residue becomes with Diluted water, followed by extraction with methylene chloride. The methylene chloride layer is over Natriumsulfat getrocknet und das Lösungsmittel abgedampft. Durch Behandlung des Rückstandes mit Benzol wird 7-ChIor-2-hydrazino-5-phenyl-3H-1,4-benzodiaze-Din erhalten. Die Umkristallisation aus einem GemischDried sodium sulfate and evaporated the solvent. By treating the residue with benzene 7-chloro-2-hydrazino-5-phenyl-3H-1,4-benzodiaze-din is obtained. Recrystallization from a mixture

von Methylenchlorid und Benzol ergibt Kristalle vom Schmelzpunkt 205 bis 2070G (Zers.). Dieses Produkt ist identisch mit dem gemäß Beispiel 1 und 5 hergestellten Produktof methylene chloride and benzene gives crystals with a melting point of 205 to 207 0 G (decomp.). This product is identical to the product produced according to Examples 1 and 5

Beispiel ,7Example, 7

; Zu einer Lösung von 1,6 Teilen 7-Chlor-3-isobutyI-2-methylmercapto-5-phenyl-3H-l,4-benzodiazepin in 150 IRaumteüen Methanol werden 40 Teile lOOVoiges Hydrazinhydrat gegeben. Das Gemisch wird 4,5 to Stunden unter Rückfluß erhitzt und in Wasser gegossen, worauf mit Chloroform extrahiert wird. Die Chloroformschicht wird mit Wasser gewaschen und über !Natriumsulfat getrocknet worauf das Lösungsmittel abgedampft wird. Durch Behandlung des Rückstandes imit Diäthyläther wird 7-Chlor-2-hydrazino-3-isobutyl-5-phenyl-3H-l,4-benzodiazepin in Forra von Kristallen erhalten. Durch Umkristallisation aus einem Gemisch yoE Chloroform und η-Hexan werden farblose Kristalle vom Schmelzpunkt 168 bis 169° C erhalten.; To a solution of 1.6 parts of 7-chloro-3-isobutyl-2-methylmercapto-5-phenyl-3H-1,4-benzodiazepine 40 parts of lOOVoiges are in 150 parts of methanol Given hydrazine hydrate. The mixture is refluxed for 4.5 to hours and poured into water, followed by extraction with chloroform. The chloroform layer is washed with water and dried over sodium sulfate whereupon the solvent is evaporated. Treatment of the residue with diethyl ether gives 7-chloro-2-hydrazino-3-isobutyl-5-phenyl-3H-1,4-benzodiazepine obtained in forra of crystals. By recrystallization from a mixture yoE chloroform and η-hexane, colorless crystals with a melting point of 168 to 169 ° C. are obtained.

Elementaranalyse:
Berechnet für Ci9H2ICIN4:
C 66,95 H 621
Gefunden:
C 6721 H 6,19
Elemental analysis:
Calculated for Ci 9 H 2 ICIN 4 :
C 66.95 H 621
Found:
C 6721 H 6.19

N 16,44
N 16,70
Beispiel 8
N 16.44
N 16.70
Example 8

2020th

2525th

Zu einer Suspension von 143 Teilen 2-Amino-7-chlor-S-phenyl-SH-t/t-benzodiazepin^N-oxyd in 400 Raumteilen Methanol werden 12,5 Raumteile 100°/oiges Hydrazinhydrat und 10 Raumteile Methanol, das mit Chlorwasserstoff gesättigt ist, gegeben. Das Gemisch wird 10 Minuten unter Rückfluß erhitzt und die erhaltene Lösung auf die Hälfte des ursprünglichen Volumens eingeengt. Das Konzentrat wird in 500 Raumteile Wasser gegossen und die erhaltene ölige Substanz mit Chloroform extrahiert. Die Chloroformschicbt wird über Natriumsulfat getrocknet und eingedampft. Durch Behandlung des Rückstandes mit Diäthyläther wird 7-Chlor-2-hydrazino-5-phenyl-3H-: l,4-benzodiazepin-4N-oxyd als blaßgelbe pulverförmige Kristalle vom Schmelzpunkt 262-263° C erhalten.To a suspension of 143 parts of 2-amino-7-chloro-S-phenyl-SH-t / t-benzodiazepine ^ N-oxide in 400 parts by volume of methanol, 12.5 parts by volume are 100% Hydrazine hydrate and 10 parts by volume of methanol, which is saturated with hydrogen chloride, are given. The mixture is refluxed for 10 minutes and the resulting solution to half of the original Confined in volume. The concentrate is poured into 500 parts by volume of water and the resulting oily Substance extracted with chloroform. The chloroform slips is dried over sodium sulfate and evaporated. By treating the residue with Diethyl ether becomes 7-chloro-2-hydrazino-5-phenyl-3H-: 1,4-benzodiazepine-4N-oxide as pale yellow powdery form Crystals with a melting point of 262-263 ° C were obtained.

Elementaranalyse:
Berechnet für Ci5HnClN4O:
C 59,90 H 436 N 18,63
Gefunden:
C 60,05 H 4,13 N 18,41
Elemental analysis:
Calculated for Ci 5 HnClN 4 O:
C 59.90 H 436 N 18.63
Found:
C 60.05 H 4.13 N 18.41

Beispiel 9Example 9

Zu einem Gemisch von 3 Teilen 2-Amino-7-nitro-5-phenyI-3H-l,4-benzodiazepin-4N-oxyd und 100 Raumteilen Äthanol werden 2£ Raurateile 100%iges Hydrazinhydrat und 1,8 Raumteile Essigsäure gegeben. Das Gemisch wird einige Zeit auf dem Wasserbad leicht erwärmt, wobei eine Lösung intsteht, und etwa 20 Minuten bei Raumtemperatur geiübru Die ausgefällten Kristalle werden abgetrennt und mit Äthanol und dann mit Diäthyläther gewaschen, wobei 2-Hydrazino-7-nitro-5-phenyl-3H-l,4-benzodiazepin-4N-oxyd in Form vct!\ gelben Nadeln vom Schmelzpunkt 176°C (Sinterung) und 226° C (Zers.) erhalten wird.To a mixture of 3 parts of 2-amino-7-nitro-5-phenyI-3H-1,4-benzodiazepine-4N-oxide and 100 parts by volume of ethanol become 2 parts of 100% hydrazine hydrate and 1.8 parts by volume of acetic acid. The mixture becomes light on the water bath for some time heated, with a solution int, and about 20 Minutes at room temperature geiübru The precipitated Crystals are separated off and washed with ethanol and then with diethyl ether, 2-hydrazino-7-nitro-5-phenyl-3H-1,4-benzodiazepine-4N-oxide in the form of yellow needles with a melting point of 176 ° C (sintering) and 226 ° C (dec.).

Elementaranalyse:
Berechnet für Ci5H13N5O3:
C 57,87 H 421 N 22,50
Gefunden:
C 5738 H 4,01 N 22,26
Elemental analysis:
Calculated for Ci 5 H 13 N 5 O 3 :
C 57.87 H 421 N 22.50
Found:
C 5738 H 4.01 N 22.26

Claims (2)

NHNH-,NHNH-, (D(D R4 R 4 worin R2 ein Wasserstoffatom oder ein Alkylrest mit 1-4 Kohlenstoffatomen ist, R3 ein Halogenatom oder eine Trifluormethylgruppe oder Nitrogruppe ist und R4 ein Wasserstoffatom oder ein Halogenatotn ist, deren N4-OxIdC sowie die Säuresalze dieser Verbindungen.wherein R 2 is a hydrogen atom or an alkyl radical having 1-4 carbon atoms, R 3 is a halogen atom or a trifluoromethyl group or nitro group and R 4 is a hydrogen atom or a halogen atom, their N 4 -OxIdC and the acid salts of these compounds. 2. Verfahren zur Herstellung von Verbindungen nach Anspruch 1, dadurch gekennzeichnet, daß man in an sich bekannter Weise2. Process for the preparation of compounds according to claim 1, characterized in that one in a manner known per se
DE19691965894 1969-11-04 1969-11-04 2-hydrazino-5-phenyl-3H-1,4-benzodiazepine derivatives and process for their preparation Expired DE1965894C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE19691965894 DE1965894C2 (en) 1969-11-04 1969-11-04 2-hydrazino-5-phenyl-3H-1,4-benzodiazepine derivatives and process for their preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19691965894 DE1965894C2 (en) 1969-11-04 1969-11-04 2-hydrazino-5-phenyl-3H-1,4-benzodiazepine derivatives and process for their preparation

Publications (2)

Publication Number Publication Date
DE1965894A1 DE1965894A1 (en) 1970-08-20
DE1965894C2 true DE1965894C2 (en) 1983-08-04

Family

ID=5755490

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19691965894 Expired DE1965894C2 (en) 1969-11-04 1969-11-04 2-hydrazino-5-phenyl-3H-1,4-benzodiazepine derivatives and process for their preparation

Country Status (1)

Country Link
DE (1) DE1965894C2 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1362322A (en) * 1962-07-10 1964-05-29 Hoffmann La Roche Process for the preparation of benzodiazepine derivatives

Also Published As

Publication number Publication date
DE1965894A1 (en) 1970-08-20

Similar Documents

Publication Publication Date Title
DE1695753A1 (en) Improvements in the preparation of 4-oxopiperidine compounds and certain new 4-oxopiperidine compounds
DE1620694B2 (en) Process for the preparation of 5-methyl-7-diethylamino-s-triazolo [1,5-a] pyrimidine and its salts with acids
DE1518764C3 (en) S-phenyl-2-oxo-23-dihydro-1H-1 ^ -benzodiazepine-S-carboxylic acid salts and alkyl esters substituted in the 7-position
DE2458638C2 (en) 4'-substituted 2-methyl-3-piperidinopropiophenone derivatives, processes for their production and pharmacological preparations which contain them
DE1965894C2 (en) 2-hydrazino-5-phenyl-3H-1,4-benzodiazepine derivatives and process for their preparation
DE3418382A1 (en) METHOD FOR THE PRODUCTION OF 1,8-DIHYDROXY-10-ACYL-9-ANTHRONES
DE1290143B (en) 2-Oxo-1, 2-dihydro-3H-1, 4-benzodiazepine derivatives
DE1944404C3 (en) Process for the preparation of 5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one derivatives
DE2302970C3 (en) Process for the preparation of 4- (1-substituted-4-piperidylidene) -4H-benzo [4,5] cyclohepta [1,2-b] thiophene-10 (9H) -ones
DE1812231B2 (en) PROCESS FOR THE PREPARATION OF 3ALKYL-5-PHENYL-1,3-DIHYDRO-2H-1,4BENZODIAZEPIN-2-ONE DERIVATIVES
DE1811831C3 (en) Process for the preparation of 5-phenyl-13-dihydro-2H-1,4-benzodiazepin-2-one derivatives
DE2265242C2 (en) Process for the preparation of tautomeric 4-phenyl-1,3-dihydro-2H-1,5-benzodiazepine-2-thiones
AT296316B (en) Process for the preparation of new benzodiazepine derivatives and their N-4-oxides
DE1493081A1 (en) Yloxytrialkylsilanes of the androstane or OEstran series and process for their production
DE1795053A1 (en) Process for the preparation of compounds of the benzodiazepine series
AT240373B (en) Process for the preparation of benzodiazepine derivatives
DE1470413A1 (en) Quaternary ammonium compounds, their manufacture and pharmaceutical preparations
DE1933523C (en) 3-Benzal-thiochroman-4-one-1-oxide
AT204547B (en) Process for the production of new oxyketones
DE1445073C (en) 3H-1,4-Benzodiazepine-4-oxides
DE1620496C (en) 1-pyridyl-3,4-dihydroisoquinolines and a process for their preparation
DE568549C (en) Process for the preparation of 2-alkoxy-5-nitropyridines
AT276401B (en) Process for the preparation of benzodiazepine derivatives
DE1545599A1 (en) Process for the preparation of new 6-hydrazino-pyridazine derivatives and their salts
DE1695213A1 (en) Process for the preparation of benzodiazepine derivatives

Legal Events

Date Code Title Description
8178 Suspension cancelled
AC Divided out of

Ref country code: DE

Ref document number: 1955349

Format of ref document f/p: P

D2 Grant after examination
8364 No opposition during term of opposition